5 Towards cannabinoid drugs - revisited

Progress in Medicinal Chemistry

Volumn 35, Issue C, 1998, Pages 199-243

  Mechoulam, R ^a   Hanus L ^a   Fride, Ester ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; APPETITE STIMULANT; CANNABINOID; CANNABINOID RECEPTOR; DRUG RECEPTOR;

ANALGESIA; DRUG EFFECT; GLAUCOMA; HUMAN; METABOLISM; MULTIPLE SCLEROSIS; REVIEW; SLEEP; SPINAL CORD INJURY;

ANALGESIA; ANTIEMETICS; ANTIHYPERTENSIVE AGENTS; APPETITE STIMULANTS; CANNABINOIDS; GLAUCOMA; HUMANS; MULTIPLE SCLEROSIS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SLEEP; SPINAL CORD INJURIES;

EID: 0032227435     PISSN: 00796468     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6468(08)70037-7     Document Type: Chapter

References (207)

1. Mechoulam R., and Feigenbaum J.J. Prog. Med. Chera. 24 (1987) 159-207
2. Kassirer J.P. N. Engl. J. Med. 336 (1997) 366
3. Kassirer J.P. N. Engl. J. Med. 336 (1997) 1186-1187
4. Gopinath L. Chem. Br. 33 (1997) 41-42
5. Pertwee R. Cannabinoid Receptors (1995), Harcourt Brace, London
6. Mechoulam R., Hanus L., and Martin B.R. Biochem. Pharmacol. 48 (1993) 1537-1544
7. Mechoulam R., Vogel Z., and Barg J. CNS Drugs 2 (1994) 255-260
8. Fride E., Hanus L., and Mechoulam R. In: Zor U. (Ed). Lipid Mediators in Health and Disease (1994), Freund Publ, London 1-10
9. Martin B.R., Welch S.P., and Abood M. Adv. Pharmacol. 25 (1994) 341-397
10. Howlett A.C. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 607-634
11. Di Marzo V., and Fontana A. Prostaglandins Leukotrienes Essent. Fatty Acids 53 (1995) 1-11
12. Piomelli D. Arachidonic Acid in Cell Signaling (1996), Chapman & Hall, New York 167-195
13. Onaivi E.S., Chakrabarti A., and Chaudhuri G. Progr. Neurobiol. 48 (1996) 275-305
14. Shohami E., Weidenfeld J., Ovadia H., Vogel Z., Hanus L., Fride E., Breuer A., Ben Shabat S., Sheskin T., and Mechoulam R. CNS Drug Rev. 2 (1996) 429-451
15. Howlett A.C., Berglund B., and Melvin L.S. Curr. Pharm. Design 1 (1998) 343-354
16. Gaoni Y., and Mechoulam R. J. Am. Chem. Soc. 86 (1964) 1646
17. Paton W.D.M. Annu. Rev. Pharmacol. 15 (1975) 191-220
18. Gill E.W., and Lawrence D.K. In: Braude M.C., and Szara S. (Eds). Pharmacology of Marihuana (1976), Raven Press, New York 147-155
19. Dewey W.L., Martin B.R., and May E.L. In: Smith D.F. (Ed). Handbook of Stereoisomers: Drugs in Psychopharmacology (1984), CRC Press, Boca Raton, FL 317-326
20. Mechoulam R., Lander N., Srebnik M., Breuer A., Segal M., Feigenbaum J.J., Jarbe T.U.C., and Consroe P. In: Rapaka R.S., and Makriyannis A. (Eds). Structure Activity Relationships of the Cannabinoids (1987), National Institute on Drug Abuse, Washington, D.C. 15-30 Monograph 79
21. Mechoulam R., Devane W.A., and Glaser R. In: Murphy L., and Bartke A. (Eds). Marijuana/Cannabinoids: Neuro-biology and Neurophysiology (1992), CRC Press, Boca Raton, FL 1-33
22. Little P.J., Compton D.R., Mechoulam R., and Martin B. Pharmacol. Biochem. Behavior 32 (1989) 661-666
23. Järbe T.U.C., Hiltunen A.J., and Mechoulam R. J. Pharmacol. Exp. Ther. 250 (1989) 1000-1005
24. A.C. Howlett, T.M. Champion, G.H. Wilken, R. Mechoulam, (1990) Neuropharma-cology29, 161-165.
25. Mechoulam R., Lander N., Breuer A., and Zahalka J. Tetrahedron: Asymmetry 1 (1990) 315-319
26. Melvin L.S., Milne G.M., Johnson M.R., Wilken G.H., and Howlett A.C. Drug Design Discov. 13 (1995) 155-166
27. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., and Howlett A.C. Mol. Pharmacol. 34 (1988) 605-613
28. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., and Ward S.J. Pharmacol. Biochem. Behav. 40 (1991) 471-478
29. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner I.I. Nature (London) 346 (1990) 561-564
30. Munro S., Thomas K.L., and Abu-Shaar M. Nature (London) 365 (1993) 61-65
31. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. Eur. J. Biochem. 232 (1995) 54-61
32. Devane W.A., Breuer A., Sheskin T., Järbe T.U.C., Eisen M., and Mechoulam R. J. Med. Chem. 35 (1992) 2065-2069
33. Devane W.A., Hanuô L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Science (Washington, D.C.) 258 (1992) 1946-1949
34. Hanuô L., Gopher A., Almog S., and Mechoulam R. J. Med. Chem. 36 (1993) 3032-3034
35. Fride E., and Mechoulam R. Eur. J. Pharmacol. 231 (1993) 313-314
36. Smith P.B., Compton D.R., Welch S.P., Razdan R.K., Mechoulam R., and Martin B.R. J. Pharmacol. Exp. Ther. 270 (1994) 219-227
37. Fride E. Brain Res. 697 (1995) 83-90
38. Childers S.R., Sexton T., and Roy M.B. Biochem. Pharmacol. 47 (1994) 711-715
39. Mackie K., Devane W., and Hille B. Mol. Pharmacol. 44 (1993) 498-503
40. Vogel Z., Barg J., Levy R., Saya D., Heldman E., and Mechoulam R. J.Neurochem. 61 (1993) 352-355
41. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., and Devane W.A. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7656-7660
42. Sulcova A., Mechoulam R., and Fride E. Pharmacol. Biochem. Behav. (1998) in press
43. Fride E., Barg J., Levy R., Saya D., Heldman R., Mechoulam R., and Vogel Z. J. Pharmacol. Exp. Ther. 272 (1995) 699-707
44. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., and Schmid H.H.O. FEBS Lett. 375 (1995) 117-120
45. Kempe K., Hsu F.-F., Bohrer A., and Turk J. J. Biol. Chem. (1996) 17287-17295
46. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Ishima Y., and Waku Y. Eur. J. Biochem. 240 (1996) 53-60
47. Cadas H., di Tomaso E., and Piomelli D. J. Neurosci. 17 (1997) 1226-1242
48. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Nature (London) 372 (1994) 686-691
49. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., and Waku K. Biochem. Biophys. Res. Commun. 218 (1996) 113-117
50. Deutsch D.G., and Chin S.A. Biochem. Pharmacol. 46 (1993) 791-796
51. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., and Gilula N.B. Nature (London) 384 (1996) 83-87
52. Deutsch G.D., Omeir R., Arreaza G., Salehani D., Prestwich G.D., Huang Z., and Howlett A. Biochem. Pharmacol. 53 (1997) 255-260
53. Fowler C.J., Stenstrom A., and Tiger G. Pharmacol. Toxicol. 80 (1997) 103-107
54. Wickens A.P., and Pertwee R.G. Eur. J. Pharmacol. 250 (1993) 205-208
55. Maneuf Y.P., Nash J.E., Crossman A.R., and Brotchie J.M. Eur. J. Pharmacol. 308 (1996) 161-164
56. Mailleux P., and Vanderhaeghen J.J. J. Neurochem. 61 (1993) 1705-1712
57. Rodriguez de Fonseca F.R., Villanua M.A., Munoz R.M., San-Martin-Ciark O., and Navarro M. Neuroendocrinology 61 (1995) 714-721
58. Romero J., Garcia L., Cebeira M., Zadrozny D., Fernandez-Ruiz J.J., and Ramos J.A. Life Sci. 56 (1995) 2033-2040
59. Shen M., Piser T.M., Seybold V.S., and Thayer S.A. J. Neurosci. 16 (1996) 4322-4334
60. Ishac E.J.N., Jiang L., Lake K.D., Varga K., Abood M.E., and Kunos G. Br. J. Pharmacol. 1181 (1996) 2023-2028
61. Fan P. J. Neurophysiol. 73 (1995) 907-910
62. Ellis E.F., Moore S.F., and Willoughby K.A. Am. J. Physiol - Heart Circ. Physiol. 381 (1995) H1859-H1864
63. Weidenfeld J., Feldman S., and Mechoulam R. Neuroendocrinology 59 (1994) 110-112
64. Venance L., Piomelli D., Glowinski J., and Giaume C. Nature (London) 376 (1995) 590-594
65. Randall M.D., Alexander S.P., Bennett T., Boyd E.A., Fry J.R., Gardiner S.M., Kemp P.A., McCulloch A.I., and Kendall D.A. Biochem. Biophys. Res. Commun. 229 (1996) 114-120
66. Schuel H., Goldstein E., Mechoulam R., Zimmerman A.M., and Zimmerman S. Proc. Natl. Acad. Sci., U.S.A. 91 (1994) 7678-7682
67. Chang M.C., Berkery D., Schuel R., Laychock S.G., Zimmerman A.M., Zimmerman S., and Schuel H. Mol. Reprod. Dev. 36 (1993) 507-516
68. Das S.K., Paria B.C., Chakraborty I., and Dey S.K. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4332-4336
69. Schmid P.G., Paria B.C., Frebsbach R.J., Schmid H.H.o., and Dey S.K. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4188-4192
70. Fried P.A. Psychopharmacology 50 (1974) 285-291
71. Fride E., and Mechoulam R. Psychoneuroendocrinology 21 (1996) 157-172
72. Fride E., Ben-Shabat S., and Mechoulam R. Soc. Neurosci. Abs. 22 (1996) 1683
73. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Biochem. Pharmacol. 50 (1995) 83-90
74. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. Biochem. Biophys. Res. Coramun. 215 (1995) 89-97
75. S. Ben-Shabat, E. Fride, Di V. Marzo, R. Mechoulam, (unpublished observations).
76. Lee M., Yang K.H., and Kaminski N.E. J. Pharmacol. Exp. Ther. 275 (1995) 529-536
77. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kisimoto S., Yamashita A., and Waku K. Biochem. Biophys. Res. Commun. 229 (1996) 58-64
78. Sugiura X., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A., and Waku K. Biochem. Biophys. Res. Commun. 233 (1997) 207-210
79. Pinto J.C., Potie F., Rice K.C., Boring D., Johnson M.R., Evans D.M., Wilken G.H., Cantrell C.H., and Howlett A.C. Mol. Pharmacol. 46 (1994) 516-522
80. Abadji V., Lin S., Taha G., Griffin G., Stevenson A., Pertwee R., and Makriyannis A. J. Med. Chem. 37 (1994) 1889-1893
81. Adams I.B., Ryan W., Singer M., Razdan R.K., Compton D.R., and Martin B.R. Life Sci. 56 (1995) 2041-2048
82. Fontana A., Di Marzo V., Cadas H., and Piomelli D. Prostaglandins Leuko-trienes Essent. Fatty Acids 53 (1995) 301-308
83. Edgemond W.S., Campbell W.B., and Hillard C.J. Prostaglandins Leukotrienes Essent. Fatty Acids 52 (1995) 83-86
84. Adams I.B., Ryan W., Singer M., Thomas B.F., Compton D.R., Razdan R.K., and Martin B.R. J. Pharmacol. Exp. Ther. 273 (1995) 1172-1181
85. Thomas B.F., Adams L.B., Mascarella W., Martin B.R., and Razdan R.K. J. Med. Chem. 39 (1996) 471-479
86. Sheskin T., Hanus L., Slager J., and Mechoulam R. J. Med. Chem. 40 (1997) 659-667
87. Showalter V.M., Compton D.R., Martin B.R., and Abood M.E. J. Pharmacol. Exp. Ther. 278 (1996) 989-999
88. Khanolkar A.D., Abadji V., Lin S., Hill W.A., Taha G., Abouzid K., Meng Z., Fan P., and Makriyannis A. J. Med. Chem. 39 (1996) 4515-4519
89. Wise M.L., Soderstrom K., Murray T.F., and Gerwick W.H. Experientia 52 (1996) 88-92
90. The nomenclature of the anandamides uses a widely accepted fatty acid numbering: the first number indicates the number of carbon atoms of the fatty acid.the second number indicates the number of double bonds (all of them skipped).the third number indicates the carbon atom (counting from the end of the fatty chain) with the first double bond
91. Razdan R.K. Pharmacol. Rev. 38 (1986) 75-149
92. B.R. Martin, B.F. Thomas, R.K. Razdan, in Ref. 5, 36-85.
93. Compton D.R., Rice K.C., De-Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., and Martin B.R. J. Pharmacol. Exp. Ther. 265 (1993) 218-226
94. Reggio P.H., McGaughey G.B., Odear D.F., Seltzman H.H., Compton D.R., and Martin B.R. Pharmacol. Biochem. Behav. 40 (1991) 479-486
95. Reggio P.H., Panu A.M., and Miles S. J. Med. Chem. 36 (1993) 1761-1771
96. Reggio P.H., Bramblett R.D., Yuknavich H., Seltzman H.H., Fleming D.N., Fernando S.R., Stevenson L.A., and Pertwee R.G. Life Sci. 56 (1995) 2025-2032
97. Lagu S.G., Varona A., Chambers J.D., and Reggio P.H. Drug Des. Discovery 12 (1995) 179-192
98. Glaser R., Adin I., Mechoulam R., and Hanuô L. Heterocycles 39 (1995) 867-877
99. Gareau Y., Dufresne C., Gallant M., Rochette C., Sawyer N., Slipetz D.M., Tremblay N., Weech P.K., Metters K.M., and Labelle M. Bioorg. Med. Chem. Lett. 6 (1996) 189-194
100. Gallant M., Dufresne C., Gareau Y., Guay D., Leblanc Y., Prasit P., Rochette C., Sawyer N., Slipetz D.M., Tremblay N., Metters K.M., and Lab M. Bioorg. Med. Chem. Lett. 6 (1996) 2263-2268
101. Huffman J.W., Yu S., Showalter V., Abood M.E., Wiley J.L., Compton D.R., Martin B.R., Bramblett R.D., and Reggio P.H. J. Med. Chem. 39 (1996) 3875-3877
102. Busch-Petersen J., Hill W.A., Fan P., Khanolkar A., Xie X.-Q., Tius M.A., and Makriyannis A. J. Med. Chem. 39 (1996) 3790-3796
103. Pertwee R.G., Fernando S.R., Griffin G., Ryan W., Razdan R.K., Compton D.R., and Martin B.R. Eur. J. Pharmacol. 315 (1996) 195-201
104. Wiley J.L., Compton D.R., Gordon P.M., Siegel C., Singer M., Dutta A., Lichtman A.H., Balster R.L., Razdan R.K., and Martin B.R. Neuropharmacology 35 (1996) 1793-1804
105. Johnson M.R., and Melvin L.S. In: Mechoulam R. (Ed). Cannabinoids as Therapeutic Agents (1986), CRC Press, Boca Raton 121-145
106. Melvin L.S., Milne G.M., Johnson M.R., Subramaniam B., Wilken G.H., and Howlett A.C. Mol. Pharmacol. 44 (1993) 1008-1015
107. D' Ambra T.E., Eissenstat M.A., Abt J., Ackerman J.H., Bacon E.R., Bell M.R., Carabateas P.M., Josef K.A., Kumar V., Weaver J.D., Arnold R., Casiano F.M., Chippari S.M., Haycock D.A., Kuster J.E., Luttinger D.A., Stevenson J.I., Ward S.J., Hill W.A., Khanolkar A., and Makriyannis A. Bioorg. Med. Chem. Lett. 6 (1996) 17-22
108. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neiliat G., Caput D., Ferrura P., Soubrie P., Breliere J.G., and Le Fur G. FEBS Lett. 350 (1994) 240-244
109. Rinaldi-Carmona M., Pialot F., Congy C., Redon E., Barth F., Bachy A., Breliere J.G., Soubrie P., and Le Fur G. Life Sci. 58 (1996) 1239-1247
110. GifTord A.N., and Ashby Jr. C.R. J. Pharmacol. Exp. Ther. 277 (1996) 1431-1436
111. Compton D.R., Aceto M.D., Lowe J., and Martin B.R. J. Pharmacol. Exp. Ther. 277 (1996) 586-594
112. Terranova J.P., Michaud J.G., Le Fur G., and Soubrie P. Naunyn-Schmiedebergs Arch. Pharmacol. 352 (1995) 576-579
113. Terranova J.P., Stortne J.J., Lafon N., Perio A., Rinaldi-Carmona M., Le Fur G., and Soubrie P. Psychopharmacology 126 (1996) 165-172
114. Pertwee R., Griffin G., Fernando S., Li X., Hill A., and Makriyannis A. Life Sci. 56 (1995) 1949-1955
115. Pertwee R.G., Fernando S.R., Nash J.E., and Coutts A.A. Br. J. Pharmacol. 118 (1996) 2199-2205
116. Yamada K., Rice K.G., Flippen-Anderson J.L., Eissenstat M.A., Ward S.J., Johnson M.R., and Howlett A.C. J. Med. Chem. 39 (1996) 1967-1974
117. Plasse T.F., Gorter R.W., Krasnow S.H., Lane M., Shepard K.V., and Wadleigh R.G. Pharmacol. Biochem. Behav. 40 (1991) 695-700
118. Lane M., Vogel C.L., Ferguson J., Krasnow S., Saiers J.L., Hamm J., Salva K., Wiernik P.H., Holroyde C.P., Hammill S., Shepard K., and Plasse T. J. Pain Symptom Manage. 6 (1991) 352-359
119. Feigenbaum J.J., Richmond S.A., Weissman Y., and Mechoulam R. Eur. J. Pharmacol. 169 (1989) 159-165
120. Fride E., and Mechoulam R. Dev. Brain Res. 95 (1996) 131-134
121. Abrahamov A., Abrahamov A., and Mechoulam R. Life Sci. 56 (1995) 2097-2102
122. Doblin R.E., and Kleiman M.A. J. Clin. Oncol. 9 (1991) 1314-1319
123. Tavorath R., and Hesketh P.J. Drugs 52 (1996) 639-648
124. Snyder S.H. Uses of Marijuana (1971), Oxford University Press, New York 6-7
125. Struwe M., Kaempfer S.H., Geiger C.J., Pavia A.T., Plasse T.F., Shepard K.V., Ries K., and Evans T.G. Ann. Pharmacother. 27 (1993) 827-831
126. Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., Lefkowitz L., Plasse T.F., and Shepard K.V. J. Pain Symptom Manage. 10 (1995) 89-97
127. Mattes R.D., Engelman K., Shaw L.M., and Elsohly M.A. Pharmacol. Biochem. Behav. 49 (1994) 187-195
128. Whitfield R.M., Bechtel L.M., and Starich G.H. Alcohol. Clin. Exp. Res. 21 (1997) 122-127
129. Himmi T., Dallaporta M., Perrin J., and Orsini J.C. Eur. J. Pharmacol. 312 (1996) 273-279
130. R. Mechoulam, in Ref. 105, pp. 1-19.
131. Lyman W.D., Sonett J.R., Brosnan C.F., Elkin R., and Bornstein M.B. Neuroim-munology 23 (1989) 73-81
132. Wirgiun I., Mechoulam R., Breuer A., Schezen E., Weidenfeld J., and Brenner T. Immunopharmacology 28 (1994) 209-214
133. Richter A., and Loscher W. Eur. J. Pharmacol. 264 (1994) 371-377
134. Pertwee R.G., and Greentree S.G. Neuropharmacology 27 (1988) 485-491
135. Consroe P., Musty R., Rein J., Tillery W., and Pertwee R.G. Eur. Neurol. 38 (1997) 44-48
136. Petro D.J., and Ellenberger C. J. Clin. Pharmacol. 21 (1981) 413-41S
137. Clifford B.D. Ann. Neurol. 13 (1983) 669-671
138. Ungerleider J.T., Andyrsiak T., Fairbanks L., Ellison G.W., and Myers L.W. Adv. Alcohol Subst. Abuse 7 (1987) 39-50
139. Meinck H.-M., Schonle P.W., and Conrad B. J. Neurol. 236 (1989) 120-122
140. Martyn C.N., Illis L.S., and Thorn J. Lancet 345 (1995) 579
141. Brenneisen R., Egli A., Elsohly M.A., Henn V., and Spiess Y. Int. J. Clin. Pharmacol. Ther. 34 (1996) 446-452
142. Maurer M., Henn V., Dittrich A., and Hofmann A. Eur. Arch. Psychiat. Clin. Neurosci. 240 (1990) 1-4
143. Greenberg H.S., Werness S.A.S., Pugh J.E., Andrus R.O., Anderson D.J., and Domino E.F. Clin. Pharmacol. Ther. 55 (1994) 324-328
144. Hollister L.E. Pharmacol. Rev. 38 (1986) 1-20
145. Ames F. J. Ment. Sci. 104 (1958) 972-999
146. Mechoulam R., Lander N., Srebnik M., Zamir I., Breuer A., Shalita B., Dikstein S., Carlini E.A., Leite J.R., Edery H., and Porath G. In: Agurell S., Dewey W.L., and Willette R.E. (Eds). The Cannabinoids, Chemical, Pharmacologic and Therapeutic Aspects (1984), Academic Press, New York 777-793
147. Welch S.P., and Stevens D.L. J. Pharmacol. Exp. Ther. 262 (1992) 10-18
148. Pugh G., Smith P.B., Dombrowski D.S., and Welch S.P. J. Pharmacol. Exp. Ther. 279 (1996) 608-616
149. Smith P.B., Welch S.P., and Martin B.R. J. Pharmacol. Exp. Ther. 268 (1994) 1381-1387
150. Reche I., Fuentes J.A., and Ruizgayo M. Eur. J. Pharmacol. 318 (1996) 11-16
151. Xu S., Cao X., Mo W., Xu Z., and Pan Y. Acupunct. Electrother. Res. 14 (1989) 103-113
152. Lichtman A.H., and Martin B.R. J. Pharmacol. Exp. Ther. 258 (1991) 517-523
153. Lichtman A.H., and Martin B.R. Brain Res. 559 (1991) 309-314
154. Welch S.P., Dunlow L.D., Patrick G.S., and Razdan R.K. J. Pharmacol. Exp. Ther. 273 (1995) 1235-1244
155. Seltzer R., Zeltser Z., Eisen A., Feigenbaum J.J., and Mechoulam R. Pain 47 (1991) 95-103
156. Burstein S.H., Audette C.A., Breuer A., Devane W.A., Colodner S., Doyle S.A., and Mechoulam R. J. Med. Chem. 35 (1992) 3135-3141
157. Evans F.J. Planta Med. 57 Suppl. 1 (1991) S60-S67
158. Herzberg U., Eliav E., Bennett G.J., and Kopin I.J. Neurosci. Lett. 221 (1997) 157-160
159. Martin W.J., Hohmann A.G., and Walker J.M. J. Neurosci. 16 (1996) 6601-6611
160. Richardson J.D., Aanonsen L., and Hargreaves K.M. Eur. J. Pharmacol. 319 (1997) R3-R4
161. J.P.D. Graham, in Ref. 105, pp. 159-166.
162. Estrada U., Brase D.A., Martin B.R., and Dewey W.L. Life Sci. 41 (1987) 79-87
163. Jones R.T. Annu. Rev. Med. 34 (1983) 247-258
164. Adams M.D., Earnhardt J.T., Martin B.R., Harris L.S., Dewey W.L., and Razdan R.K. Experientia 33 (1977) 1204-1205
165. Zaugg H.E., and Kyncl J. J. Med. Chem. 26 (1983) 214-217
166. Vidrio H., SanchezSalvatori M.A., and Medina M. J. Cardiovasc. Pharmacol. 28 (1996) 332-336
167. Varga K., Lake K., Martin B.R., and Kunos G. Eur. J. Pharmacol. 278 (1995) 279-283
168. Varga K., Lake K.D., Huangfu D., Guyenet P.G., and Kunos G. Hypertension 28 (1996) 682-686
169. Wagner J.A., Varga K., Ellis E.F., Rzigalinski B.A., Martin B.R., and Kunos G. Nature (London) 390 (1997) 518-521
170. Randall M.D., and Kendall D.A. Eur. J. Pharmacol. 331 (1997) 205-209
171. Vanhoutte P.M. J. Hypertension (1996) S83-S93 Suppl. 14
172. Colasanti B.K., Graig C.R., and Allara R.D. Exp. Eye Res. 39 (1989) 251-255
173. Colasanti B.K. J. Ocul. Pharmacol. 6 (1990) 259-269
174. Liu J.H., and Dacus A.C. Arch. Ophthalmol. 105 (1987) 245-248
175. W. Devane, R. Mechoulam, A. Breuer, L. Hanus, (1994) PCT/US93/11625.
176. Pate D.W., Jarvinen K., Uritti A., Jarho P., and Jarvinen T. Curr. Eye Res. 14 (1995) 791-797
177. Pate D.W., Jarvinen K., Urtti A., Jarho P., Fich M., Mahadevan V., and Jarvinen T. Life Sci. 58 (1996) 1849-1860
178. Benowitz N.L., and Jones R.T. Clin. Pharmacol. Ther. 22 (1977) 259-268
179. Paton W.D.M., and Pertwee R. Br. J. Pharmacol. 44 (1972) 250-261
180. Oishi R., Itoh Y., Nishibori M., Saeki K., and Ueki S. Psychopharmacology 95 (1988) 77-81
181. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., and Lerner R.A. Science (Washington, D.C.) 268 (1995) 1506-1509
182. Huidobro-Toro J.P., and Harris R.A. Proc. Natl. Acad. Sci, U.S.A. 93 (1996) 8078-8082
183. Santucci V., Storme J.J., Soubrie P., and Le Fur G. Life Sci. 58 (1996) PL103-PL110
184. Mechoulam R., Fride E., Hanuô L., Sheskin T., Bisogno T., DiMarzo V., Buyewitch M., and Vogel Z. Nature (London) 389 (1997) 25-26
185. Boring D.L., Berglund B.A., and Howlett A.C. Prostaglandins Leukotrienes Essent. Fatty Acids 55 (1996) 207-210
186. Guimaraes F.S., Chiaretti T.M., Graeff F.G., and Zuardi A.W. Psychopharmacology 100 (1990) 558-559
187. Zuardi A.W., Morais S.L., Guimaraes F.S., and Mechoulam R. J. Clin. Psychiatr. 56 (1995) 485-486
188. Zuardi A.W., Shirakawa I., Finkelfarb E., and Karniol I.G. Psychopharmacology 76 (1982) 245-250
189. Mechoulam R., Shani A., Edery H., and Grunfeld Y. Science, (Washington, D.C.) 169 (1970) 611-612
190. Thompson G.R., Rosenkrantz H., Schaeppi U.H., and Braude M.C. Toxicol. Appl. Pharmacol. 25 (1973) 363-372
191. Hollister L.E., and Gillespie H.K. Clin. Pharmacol. Ther. 14 (1973) 353-357
192. Zias J., Stark H., Seligman J., Levy R., Werker E., Breuer A., and Mechoulam R. Nature (London) 363 (1993) 315
193. Feigenbaum J.J., Bergmann E., Richmond S.A., Mechoulam R., Nadler V., Kloog Y., and Sokolovsky M. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9584-9587
194. Nadler V., Mechoulam R., and Sokolovsky M. Brain Res. 622 (1993) 79-85
195. Nadler V., Mechoulam R., and Sokolovsky M. Neurosci. Lett. 162 (1993) 43-45
196. Eshhar N., Streim S., and Biegon A. NeuroRep. 5 (1993) 237-240
197. Eshhar N., Streim S., Kohen R., Tirosh O., and Biegon A. Eur. J. Pharmacol. 283 (1995) 1-3
198. Shohami E., Novikov M., and Mechoulam R. J. Neurotrauma 10 (1993) 109-119
199. Shohami E., Novikov M., and Bass R. Brain Res. 674 (1995) 55-62
200. Shohami E., Gallily R., Mechoulam R., Bass R., and Ben-Hur T. J. Neuroim-munol. 72 (1997) 169-177
201. Bass R., Trembovler V., Engelhard D., and Shohami E. J. Infect. Dis. 173 (1996) 735-738
202. Belayev L., Bar-Joseph A., Adamchik J., and Biegon A. Mol. Chem. Neuro-phathol. 25 (1995) 19-33
203. Bar-Joseph A., Berkovitch Y., Adamchik J., and Biegon A. Mol. Chem. Neuropathol. 23 (1994) 125-135
204. Yoles E., Belkin M., and Schwartz M. J. Neurotrauma 13 (1995) 49-57
205. Biegon A., and Bar-Joseph A. Neurol. Res. 17 (1995) 275-280
206. Pop E., Liu Z.Z., Brewster M.E., Barenholz Y., Korablyov V., Mechoulam R., Nadler V., and Biegon A. Pharm. Res. 13 (1996) 62-69
207. Pop E., Soti F., Brewster M.E., Barenholz Y., Korablyov V., Mechoulam R., Nadler V., and Biegon A. Pharm. Res. 13 (1996) 469-475